Here are three stocks with buy ranks and strong growth characteristics for investors to consider today January 16th: Novo Nordisk (NVO) : This global healthcare company which is a leader in the worldwide diabetes market with a full portfolio of GLP-1 receptor agonists, modern insulins and human insulins, carries a Zacks Rank #1 (Strong Buy), and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days. Novo Nordisk has a PEG ratio of 1.24 compared with 2 ...